| Mechanisms of immunotoxicity: stressors and evaluators M Bou Zerdan, S Moussa, A Atoui, HI Assi International Journal of Molecular Sciences 22 (15), 8242, 2021 | 35 | 2021 |
| Thalassemia in the emergency department: special considerations for a rare disease AN Saliba, A Atoui, M Labban, H Hamade, R Bou-Fakhredin, A Mufarrij, ... Annals of Hematology 99, 1967-1977, 2020 | 19 | 2020 |
| Deep venous thrombosis and pulmonary embolism after COVID-19 mRNA vaccination A Atoui, K Jarrah, L Al Mahmasani, R Bou-Fakhredin, AT Taher Annals of Hematology 101 (5), 1111-1113, 2022 | 17 | 2022 |
| The use of intrathecal chemotherapy and dexamethasone for secondary prevention of blinatumomab-related neurotoxicity. A Aqel, O Fakhreddine, A Atoui, N Moukalled, J El Cheikh, A Bazarbachi, ... Current Research in Translational Medicine 69 (2), 103285-103285, 2021 | 7 | 2021 |
| Latest updates on cellular and molecular biomarkers of gliomas M Bou Zerdan, A Atoui, A Hijazi, L Basbous, R Abou Zeidane, SM Alame, ... Frontiers in Oncology 12, 1030366, 2022 | 6 | 2022 |
| The elephant in the room: AML relapse post allogeneic hematopoietic cell transplantation I Abou Dalle, A Atoui, A Bazarbachi Frontiers in Oncology 11, 793274, 2022 | 6 | 2022 |
| Complete remission of seronegative rheumatoid arthritis following haplo-identical stem cell transplantation for peripheral T-cell lymphoma A Atoui, M El Labban, N Ghaoui, H El Darsa, J El Cheikh, A Bazarbachi Bone Marrow Transplantation 55 (5), 979-981, 2020 | 5 | 2020 |
| Clinical significance of breast cancer molecular subtypes and ki67 expression as a predictive value for pathological complete response following neoadjuvant chemotherapy … A Atoui, M Bou Zerdan, A El Mahmoud, N Chamseddine, L Hamad, ... International Journal of Breast Cancer 2022 (1), 1218128, 2022 | 4 | 2022 |
| The use of voriconazole as primary prophylaxis for invasive fungal infections in patients undergoing allogeneic stem cell transplantation: a single center’s experience A Atoui, N Omeirat, O Fakhreddine, R El Alam, Z Kanafani, I Abou Dalle, ... Journal of Fungi 7 (11), 925, 2021 | 4 | 2021 |
| Successful treatment of severe aplastic anemia with syngeneic stem cell transplantation in the setting of active disseminated mucormycosis J El-Cheikh, A Atoui, N Moukalled, N Ghaoui, H El Darsa, SS Kanj, ... Medical mycology case reports 23, 68-71, 2019 | 4 | 2019 |
| Manifestation of paroxysmal nocturnal hemoglobinuria after COVID-19 mRNA vaccination K Jarrah, L Al Mahmasani, A Atoui, R Bou-Fakhredin, AT Taher Blood Cells, Molecules & Diseases 93, 102641, 2022 | 3 | 2022 |
| Clofarabine and total body irradiation (TBI) as conditioning regimen for allogeneic stem cell transplantation in high-risk acute leukemia patients: a two-center retrospective … J El Cheikh, G Bidaoui, A Atoui, K Terro, L Sharrouf, A Zahreddine, ... Bone Marrow Transplantation 58 (6), 667-672, 2023 | 2 | 2023 |
| Characteristics and Clinical Outcomes of Patients Referred to a Cardio-Oncology Clinic: The First Lebanese Experience O Fakhreddine, I Alameh, A Atoui, A Taher, A Bazarbachi, H Skouri | | 2023 |
| POSTER: MCL-520 VR-CAP Alternating With R-DHAP First-Line Induction Regimen for Newly Diagnosed Mantle Cell Lymphoma (MCL): A Retrospective Review of 10 Patients M Mourad, A Atoui, A Zahreddine, N Moukalled, J El Cheikh, ... Clinical Lymphoma Myeloma and Leukemia 23, S212, 2023 | | 2023 |
| MCL-520 VR-CAP Alternating With R-DHAP First-Line Induction Regimen for Newly Diagnosed Mantle Cell Lymphoma (MCL): A Retrospective Review of 10 Patients M Mourad, A Atoui, A Zahreddine, N Moukalled, J El Cheikh, ... Clinical Lymphoma Myeloma and Leukemia 23, S463, 2023 | | 2023 |
| Poster: CT-028 Clofarabine and Total Body Irradiation as a Conditioning Regimen for Allogeneic Stem Cell Transplantation in High-Risk Acute Leukemia A Atoui, R Dulery, K Terro, I Abou Dalle, A Bazarbachi, M Mohty, ... Clinical Lymphoma, Myeloma and Leukemia 22, S186, 2022 | | 2022 |
| CT-028 Clofarabine and Total Body Irradiation as a Conditioning Regimen for Allogeneic Stem Cell Transplantation in High-Risk Acute Leukemia A Atoui, R Dulery, K Terro, I Abou Dalle, A Bazarbachi, M Mohty, ... Clinical Lymphoma Myeloma and Leukemia 22, S432, 2022 | | 2022 |
| Outcome of cancer patients affected by COVID-19 in different settings. A El Mahmoud, P El-Meouchy, N Chamseddine, EJ Karam, W Khaled, ... Journal of Clinical Oncology 40 (16_suppl), e18709-e18709, 2022 | | 2022 |
| Poster: AML-270: Outcomes of Patients with Relapsed/Refractory Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation in Active Disease A Atoui, A Aqel, A Zahreddine, J El Cheikh, A Bazarbachi, I Abou Dalle Clinical Lymphoma Myeloma and Leukemia 21, S215, 2021 | | 2021 |
| B-Cell Lymphoblastic Lymphoma in Relapse Presenting as a Uterine Mass: A Case Report and Review of Literature R Abou Chakra, B Najib, W Abdallah, M Akiki, L El Khoury, A Atoui, ... Case Reports in Oncology 14 (2), 868-873, 2021 | | 2021 |
